4, 2024 — A treatment paradox has recently come to light in prostate cancer ... disease progression in patients whose disease has advanced. The inability ... Targeted Cancer Therapies: Getting ...

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial. Nature Medicine , 2024; DOI: 10.1038/s41591-024-03204-2 Cite This Page : ...

Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease—it could be a ...

A rare super blue moon will light up the sky on Monday, Aug. 19. It's a rarity of sorts, according to NASA, since the ...

Charities and doctors have welcomed the King going public about needing treatment for an enlarged prostate. It could encourage men with similar symptoms to get a check-up, they say. An enlarged ...

(Photo Credit: DigitalVision/Getty Images) Metastatic prostate cancer is an advanced form of cancer. There's no cure, but you take steps to treat and control it. Most people with advanced prostate ...

What Is a Prostate Exam? A prostate exam is a test that checks for early signs of prostate cancer. It doesn't reveal cancer, but if the test shows an abnormal result, your doctor will likely need ...

These rates are typically grouped by how advanced the cancer is when someone receives the diagnosis. Localized prostate cancer is when the cancer hasn’t spread outside of your prostate.

When a diagnosis is made before the cancer has spread outside of the prostate, treatment options are highly effective and long-term prognosis is favorable. But many are diagnosed in advanced ...

Radiotherapy to the prostate alongside standard treatment can keep some men with advanced prostate cancer alive for longer without detriment to quality of life, long-term study results confirm.

Prostate zonal anatomy is best demonstrated with MRI. On T2-weighted sequences, the normal prostate can be divided into the peripheral zone, which shows high signal intensity owing to its high ...

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown. Researchers found that a ...